These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38232641)

  • 1. Evaluation of the cytotoxic and immunomodulatory effects of sonodynamic therapy in human pancreatic cancer spheroids.
    Foglietta F; Panzanelli P; Pizzo R; Giacone M; Pepa CD; Durando G; Serpe L; Canaparo R
    J Photochem Photobiol B; 2024 Feb; 251():112842. PubMed ID: 38232641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Triggers Hypericin Activation Leading to Multifaceted Anticancer Activity.
    Foglietta F; Canaparo R; Cossari S; Panzanelli P; Dosio F; Serpe L
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive Nanoliposomes for Enhanced Sonodynamic-Triggered Disulfidptosis-Like Cancer Cell Death via Lipid Peroxidation.
    Xiang H; Shen B; Zhang C; Li R
    Int J Nanomedicine; 2024; 19():8929-8947. PubMed ID: 39246429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-targeting sonosensitizer-loaded extracellular vesicles for chemo-sonodynamic therapy.
    Nguyen Cao TG; Truong Hoang Q; Hong EJ; Kang SJ; Kang JH; Ravichandran V; Kang HC; Ko YT; Rhee WJ; Shim MS
    J Control Release; 2023 Feb; 354():651-663. PubMed ID: 36682729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma.
    Hadi MM; Farrell S; Nesbitt H; Thomas K; Kubajewska I; Ng A; Masood H; Patel S; Sciscione F; Davidson B; Callan JF; MacRobert AJ; McHale AP; Nomikou N
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5007-5023. PubMed ID: 36319895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonodynamic Therapy-Driven Immunotherapy: Constructing AIE Organic Sonosensitizers Using an Advanced Receptor-Regulated Strategy.
    Tian M; Li Y; Li Y; Yang T; Chen H; Guo J; Liu Y; Liu P
    Small; 2024 Sep; 20(37):e2400654. PubMed ID: 38752582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
    Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
    Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
    [No Abstract]   [Full Text] [Related]  

  • 8. TiSe
    Chen L; Xue W; Cao J; Zhang S; Zeng Y; Ma L; Qian X; Wen Q; Hong Y; Shi Z; Xu Y
    J Nanobiotechnology; 2022 Oct; 20(1):453. PubMed ID: 36243711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal Complexes for Cancer Sonodynamic Therapy.
    Mandal AA; Kushwaha R; Yadav AK; Banerjee S
    Chembiochem; 2023 Mar; 24(6):e202200597. PubMed ID: 36385722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile Synthesis of a Multifunctional Porous Organic Polymer Nanosonosensitizer (mHM@HMME) for Enhanced Cancer Sonodynamic Therapy.
    Li M; Liu Z; Tang J; Cheng L; Xue Y; Liu Y; Liu J
    ACS Appl Mater Interfaces; 2024 Jun; 16(22):28104-28117. PubMed ID: 38769350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic Decoy Inhibits Tumor Growth and Lung Metastasis by Reversing the Drawbacks of Sonodynamic Therapy.
    Zhao H; Zhao B; Li L; Ding K; Xiao H; Zheng C; Sun L; Zhang Z; Wang L
    Adv Healthc Mater; 2020 Jan; 9(1):e1901335. PubMed ID: 31762228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Challenges of Sonodynamic Therapy System for Cancer Theranostics: From Equipment to Sensitizers.
    Gong Z; Dai Z
    Adv Sci (Weinh); 2021 May; 8(10):2002178. PubMed ID: 34026428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer.
    Wu W; Xu M; Qiao B; Huang T; Guo H; Zhang N; Zhou L; Li M; Tan Y; Zhang M; Xie X; Shuai X; Zhang C
    Acta Biomater; 2023 Mar; 158():547-559. PubMed ID: 36539109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosting the Sonodynamic Cancer Therapy Performance of 2D Layered Double Hydroxide Nanosheet-Based Sonosensitizers Via Crystalline-to-Amorphous Phase Transformation.
    Hu T; Shen W; Meng F; Yang S; Yu S; Li H; Zhang Q; Gu L; Tan C; Liang R
    Adv Mater; 2023 Apr; 35(17):e2209692. PubMed ID: 36780890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonodynamic Therapy and Sonosensitizers for Glioma Treatment: A Systematic Qualitative Review.
    Mehta NH; Shah HA; D'Amico RS
    World Neurosurg; 2023 Oct; 178():60-68. PubMed ID: 37454909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioma stem-like cells are less susceptible than glioma cells to sonodynamic therapy with photofrin.
    Xu ZY; Li XQ; Chen S; Cheng Y; Deng JM; Wang ZG
    Technol Cancer Res Treat; 2012 Dec; 11(6):615-23. PubMed ID: 22775340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cancer.
    Nicholas D; Nesbitt H; Farrell S; Logan K; McMullin E; Gillan T; Kelly P; O'Rourke D; Porter S; Thomas K; O'Hagan BMG; Nomikou N; Callan B; Callan JF; McHale AP
    Eur J Pharm Biopharm; 2021 Jun; 163():49-59. PubMed ID: 33798727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonosensitizer nanoplatform-mediated sonodynamic therapy induced immunogenic cell death and tumor immune microenvironment variation.
    Zheng J; Sun Y; Long T; Yuan D; Yue S; Zhang N; Yang Z
    Drug Deliv; 2022 Dec; 29(1):1164-1175. PubMed ID: 35393920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titanium-Based Nanoarchitectures for Sonodynamic Therapy-Involved Multimodal Treatments.
    Maleki A; Seyedhamzeh M; Yuan M; Agarwal T; Sharifi I; Mohammadi A; Kelicen-Uğur P; Hamidi M; Malaki M; Al Kheraif AA; Cheng Z; Lin J
    Small; 2023 Mar; 19(12):e2206253. PubMed ID: 36642806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells.
    Xie W; Zhu S; Yang B; Chen C; Chen S; Liu Y; Nie X; Hao L; Wang Z; Sun J; Chang S
    Int J Nanomedicine; 2019; 14():9377-9393. PubMed ID: 31819438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.